Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Incyte Corporation aggregated by PharmaCompass.com.

    Client Virtual Booth

    INCYTE CORPORATION

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Incyte Corporation
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1801 Augustine Cut-off Wilmington, DE 19803
    Telephone
    Telephone
    +1 1.855.446.2983
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.incyte.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    left grey arrow
    right gray arrow
    Full View ScreenFull Screen View
    Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
    Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists

    https://www.escientpharma.com/incyte-announces-acquisition-of-escient-pharmaceuticals-and-its-pipeline-of-first-in-class-oral-mrgpr-antagonists/

    PRESS RELEASE
    24 Apr 2024
    Share Share
    Incyte Biologic Zynyz (retifanlimab-dlwr) Receives Approval in the U.S.
    Incyte Biologic Zynyz (retifanlimab-dlwr) Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761334

    FDA
    22 Apr 2024
    Share Share
    CMS & Incyte collaborate to develop vitiligo drug Povorcitinib in China
    CMS & Incyte collaborate to develop vitiligo drug Povorcitinib in China

    https://www.biospectrumasia.com/news/25/24039/cms-and-incyte-collaborate-to-develop-vitiligo-drug-povorcitinib-in-china-and-southeast-asia.html

    BIOSPECTRUM ASIA
    04 Apr 2024
    Share Share
    Ironwood spies new frontier for $1B drug in exploratory trial
    Ironwood spies new frontier for $1B drug in exploratory trial

    https://www.fiercebiotech.com/biotech/ironwood-spies-new-frontier-1b-drug-exploratory-rare-disease-trial

    FIERCE BIOTECH
    29 Mar 2024
    Share Share
    Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    https://www.businesswire.com/news/home/20240329198758/en

    BUSINESSWIRE
    29 Mar 2024
    Share Share
    Incyte's oral Dupixent rival hits in midphase skin disease trial
    Incyte's oral Dupixent rival hits in midphase skin disease trial

    https://www.fiercebiotech.com/biotech/incyte-itching-piece-dupixents-market-hits-goals-midphase-skin-disease-trial

    FIERCE BIOTECH
    12 Mar 2024
    Share Share
    Incyte's Opzelura scores in hidradenitis suppurativa study
    Incyte's Opzelura scores in hidradenitis suppurativa study

    https://www.fiercepharma.com/pharma/incytes-jak-cream-opzelura-proves-its-worth-treating-hidradenitis-suppurativa-phase-2-study

    Zoey Becker FIERCE PHARMA
    11 Mar 2024
    Share Share
    Incyte Presents Late-Breaking Data from Phase 2 Study Evaluating Povorcitinib
    Incyte Presents Late-Breaking Data from Phase 2 Study Evaluating Povorcitinib

    https://www.businesswire.com/news/home/20240310275231/en

    BUSINESSWIRE
    10 Mar 2024
    Share Share
    Incyte Announces New Data from Phase 2 Study Evaluating Ruxolitinib Cream
    Incyte Announces New Data from Phase 2 Study Evaluating Ruxolitinib Cream

    https://www.businesswire.com/news/home/20240310012701/en

    BUSINESSWIRE
    10 Mar 2024
    Share Share
    New Data from Incyte’s Growing Dermatology Portfolio to be Presented
    New Data from Incyte’s Growing Dermatology Portfolio to be Presented

    https://www.businesswire.com/news/home/20240304329736/en

    BUSINESSWIRE
    04 Mar 2024
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search